‘ We are changing the world of healthcare and transforming clinical practice ’
Active clinical decision support technology Enables design, creation and execution of clinical pathwaysProvides evidence-based recommendationsfor each individual patientImproves care outcomes, whilst reducing delivery costs
Proven, flexible, user-friendly EDC solutionPowerful study design tool requiring no programming skillsStudy hosting service available, reducing IT and infrastructure overheadsDesigned to support regulatory compliance
Arezzo® lies at the heart of both
Arezzo Pathways and MACRO™
InferMed solutions help healthcare users comply with best practice pathways and protocols to get healthcare right, first time, every time.
InferMed is a business solutions software company enabling healthcare users to make complex decisions more efficiently and effectively, using its award-winning Arezzo clinical decision support technology
The Newcastle Clinical Trials Unit (NCTU) selected MACRO in the spring of 2013 as its new online clinical data management system and today we can report on a series of trials that are fully exploiting MACRO's study design potential.
18 September 2014
InferMed today reports a milestone in the usage of the Arezzo-based eReferrals system developed by its New Zealand partner, the Best Practice Advocacy Centre (BPAC Inc.). In August 2014 Midland Health Network and other central north island health organisations celebrated more than half a million electronic referrals (eReferrals) having been sent between Midland general practices, community specialists, and DHB hospitals in the Midland region of New Zealand.
17 September 2014
InferMed will be attending the EMIS National User Group conference from September 24th to 26th at the East Midlands Conference Centre in Nottingham and will be showcasing Arezzo Pathways, the advanced clinical decision support application available for use in primary and secondary care settings throughout the NHS.
08 September 2014
Thank you. Your request has been received. We will contact you shortly.